Stay updated on Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial
Sign up to get notified when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.

Latest updates to the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page
- Check5 days agoChange DetectedA new revision tag v3.6.4 was added to the study record history, and the previous revision tag v3.6.3 was removed. This reflects an update to the page's versioning metadata within the record history.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe study record history now shows the latest revision as v3.6.3, replacing the prior v3.6.2 in the version history.SummaryDifference0.1%

- Check33 days agoChange DetectedA new revision entry (v3.6.2) was added to the study's history, and the previous revision (v3.6.0) was removed from the history, indicating a version update to the page.SummaryDifference0.1%

- Check47 days agoChange DetectedAdded a note that recruitment is no longer being pursued and recorded a new record revision v3.6.0; the previous revision v3.5.5 entry was removed.SummaryDifference0.4%

- Check55 days agoChange DetectedThe study record history shows a new revision label v3.5.5 added, replacing the prior v3.5.4.SummaryDifference0.1%

- Check76 days agoChange DetectedA new page revision, v3.5.4, was added to the record history, replacing the previous v3.5.3 and signaling an update to the page's version metadata. This change reflects the latest build of the page rather than core content or functionality.SummaryDifference0.1%

Stay in the know with updates to Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.